Why the study?
Does consistent use of secondary preventive medications improve prognosis in patients after their first acute coronary syndrome?
Does consistent use of secondary preventive medications improve prognosis in patients after their first acute coronary syndrome?
Evidence-based secondary prevention medications are underutilized in post-ACS patients, particularly among the elderly and diabetics, though consistent use improves prognosis.
Supports adherence optimization post-ACS; leaves open causal confirmation via randomized trials.
Our study showed that the evidence-based use of medications after acute coronary syndrome was suboptimal in Finland, particularly in elderly and diabetic patients. Consistent use of these medications, however, was associated with a better prognosis.
No takes yet. Share an insight, caveat, or question.
Salomaa et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: